Angelman Syndrome Natural History Study
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- Boston Children's Hospital
- Study ID
- NCT04507997
- Status
- Recruiting
Conditions
- Angelman Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Study Details
The goal of this study is to conduct a prospective, longitudinal natural history study of children and adults with Angelman Syndrome using investigator-observed and parent-reported outcome measures to obtain data that will be useful for future clinical trials.
Key Dates
- Start date
- Aug 1, 2018
- Status verified
- Mar 2025
- Primary completion
- Apr 30, 2031
- Completion
- Apr 30, 2031
Study Design
- Enrollment
- 300 participants (estimated)
Primary Outcome Measure
Medical History [ Time Frame: Through study completion, an average of 1 year ]
Central Contacts
- Wen-Hann Tan, BMBS617-355 6394
- Batsheva Friedman, MA617-355-2030
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cedars-Sinai Guerin Children's | Los Angeles | California | 90048 | Cesar Ochoa-Lubinoff, MD, MPH (PRINCIPAL_INVESTIGATOR) |
| Rady Children's Hospital, San Diego | San Diego | California | 92123 | Lynne M. Bird, MD (PRINCIPAL_INVESTIGATOR) |
| Children's Hospital Colorado, Anschutz Medical Campus | Aurora | Colorado | 80045 | Diana Walleigh, MD (PRINCIPAL_INVESTIGATOR) |
| Emory University School of Medicine | Atlanta | Georgia | 30322 | Amy L. Talboy, MD (PRINCIPAL_INVESTIGATOR) |
| Rush University Children's Hospital | Chicago | Illinois | 60612 | Elizabeth Berry-Kravis, MD, PhD (PRINCIPAL_INVESTIGATOR) |
| Boston Children's Hospital | Boston | Massachusetts | 02115 | Wen-Hann Tan, BMBS |
| The Carolina Institute for Developmental Disabilities | Carrboro | North Carolina | 27510 | Margaret DeRamus, MS, CCC-SLP (PRINCIPAL_INVESTIGATOR) |
| Monroe Carell Jr. Children's Hospital at Vanderbilt | Nashville | Tennessee | 37232 | Robert Carson, MD, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Los Angeles, CA
By research site
Related Studies
- Early Check: Expanded Screening in NewbornsEnrolling By Invitation · RTI International · Research Triangle Park, North Carolina
- Parent and Infant Inter(X)Action Intervention (PIXI)Enrolling By Invitation · RTI International · Research Triangle Park, North Carolina
- HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Participants With Angelman SyndromePHASE1/PHASE2 · Recruiting · Ionis Pharmaceuticals, Inc. · San Diego, California
- Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)Recruiting · Rush University Medical Center · Chicago, Illinois